Myeloid neoplasm associated with FGFR1 rearrangement

Hematologic neoplasms characterized by the rearrangement of the FGFR1 gene, resulting in translocations with an 8p11 breakpoint. Patients present with a myeloproliferative neoplasm, acute myeloid leukemia, lymphoblastic lymphoma/leukemia of T or B-cell lineage, or acute leukemia of mixed phenotype.

Also known as: 8p11 myeloproliferative syndrome, 8p11 stem cell leukemia/lymphoma syndrome, 8p11 stem cell syndrome, chromosome 8p11 myeloproliferative syndrome, myeloid and lymphoid neoplasms associated with FGFR1 abnormalities, myeloid and lymphoid neoplasms with FGFR1 rearrangement, myeloid/lymphoid neoplasm associated with FGFR1 rearrangement, myeloid/lymphoid neoplasms with FGFR1 rearrangement

1843 clinical trials for this condition and its sub-types, 2 tagged with Myeloid neoplasm associated with FGFR1 rearrangement itself.